
Adaptimmune Therapeutics PLC
ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31
Reports and events: 279 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-05-0614:57 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001558370-19-004059 |
| 2019-05-0608:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-026974 |
| 2019-05-0607:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-026967 |
| 2019-05-0607:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-026958 |
| 2019-05-0216:56 ET | 8-K | 5.07 Shareholder vote results | 0001104659-19-026508 |
| 2019-05-0207:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-026207 |
| 2019-04-0208:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-019174 |
| 2019-03-1517:01 ET | DEF 14A | Proxy statementPeriod 2019-05-02 | 0001047469-19-001324 |
| 2019-02-2717:22 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001558370-19-001209 |
| 2019-02-2717:16 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-011164 |
| 2019-02-2707:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-010927 |
| 2019-01-0707:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-000986 |
| 2018-12-1208:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-18-072463 |
| 2018-11-0610:58 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001104659-18-066229 |
| 2018-11-0607:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-18-066178 |
| 2018-10-2208:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-063179 |
| 2018-10-1014:37 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-18-000810 |
| 2018-09-1715:45 ET | SC 13D | Ownership report, active investor | 0001072613-18-000476 |
| 2018-09-0713:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-055759 |
| 2018-09-0507:50 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-055198 |
| 2018-08-1507:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-052132 |
| 2018-08-0212:13 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001104659-18-049058 |
| 2018-08-0207:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-18-048987 |
| 2018-07-2407:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-046630 |
| 2018-07-1817:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-045789 |
| 2018-07-0617:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-18-044174 |
| 2018-06-2017:00 ET | 8-K | 5.07 Shareholder vote results | 0001104659-18-041291 |
| 2018-06-0407:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-037806 |
| 2018-05-0912:32 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001104659-18-031628 |
| 2018-05-0907:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-18-031514 |
| 2018-04-2717:00 ET | DEF 14A | Proxy statementPeriod 2018-06-20 | 0001047469-18-003307 |
| 2018-04-1217:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-18-023736 |
| 2018-03-2917:24 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-18-000304 |
| 2018-03-1511:29 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001104659-18-017694 |
| 2018-03-1507:42 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-017637 |
| 2018-01-2614:36 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-18-000062 |
| 2018-01-0808:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-001125 |
| 2018-01-0808:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-18-001123 |
| 2017-11-1316:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-067996 |
| 2017-11-0210:46 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001104659-17-065442 |
| 2017-11-0208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-17-065389 |
| 2017-09-0707:40 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-055957 |
| 2017-08-0311:53 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001104659-17-049218 |
| 2017-08-0307:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-17-049119 |
| 2017-07-2416:45 ET | 8-K | 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001104659-17-046539 |
| 2017-07-0316:45 ET | 8-K | 8.01 Other events | 0001104659-17-043258 |
| 2017-06-2116:45 ET | 8-K | 5.07 Shareholder vote results | 0001104659-17-040686 |
| 2017-06-0608:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-037598 |
| 2017-06-0510:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-037379 |
| 2017-05-2615:52 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-035681 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.